Monarch Capital Management Inc Organon & Co. Transaction History

Monarch Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$31.66 - $38.9 $22,636 - $27,813	-715 Reduced 8.24%	7,963 $269,000
Q1 2022 Apr 20, 2022	SELL	$30.45 - $39.36 $43,604 - $56,363	-1,432 Reduced 14.16%	8,678 $303,000
Q4 2021 Jan 19, 2022	SELL	$28.67 - $37.13 $67,345 - $87,218	-2,349 Reduced 18.85%	10,110 $308,000
Q3 2021 Nov 04, 2021	SELL	$28.63 - $35.64 $39,681 - $49,397	-1,386 Reduced 10.01%	12,459 $409,000
Q2 2021 Jul 22, 2021	BUY	$28.45 - $38.0 $393,890 - $526,110	13,845 New	13,845 $419,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Monarch Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Monarch Capital Management Inc with notifications on news.